Report Detail
Global Prostate Cancer Diagnostics Market Growth 2019-2024
- RnM3050794 |
- 05 March, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
According to this study, over the next five years the Prostate Cancer Diagnostics market will register a 7.9% CAGR in terms of revenue, the global market size will reach US$ 15800 million by 2024, from US$ 10000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostate Cancer Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key manufacturers and key regions and countries.
This study considers the Prostate Cancer Diagnostics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
age < 55
age 55-75
age > 75
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostate Cancer Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Prostate Cancer Diagnostics market by identifying its various subsegments.
Focuses on the key global Prostate Cancer Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostate Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Prostate Cancer Diagnostics Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Prostate Cancer Diagnostics Consumption 2014-2024
- 2.1.2 Prostate Cancer Diagnostics Consumption CAGR by Region
- 2.2 Prostate Cancer Diagnostics Segment by Type
- 2.2.1 Tumor Biomarker Tests
- 2.2.2 Imaging
- 2.2.3 Biopsy
- 2.2.4 Other
- 2.3 Prostate Cancer Diagnostics Consumption by Type
- 2.3.1 Global Prostate Cancer Diagnostics Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Prostate Cancer Diagnostics Sale Price by Type (2014-2019)
- 2.4 Prostate Cancer Diagnostics Segment by Application
- 2.4.1 age < 55
- 2.4.2 age 55-75
- 2.4.3 age > 75
- 2.5 Prostate Cancer Diagnostics Consumption by Application
- 2.5.1 Global Prostate Cancer Diagnostics Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Prostate Cancer Diagnostics Value and Market Share by Application (2014-2019)
- 2.5.3 Global Prostate Cancer Diagnostics Sale Price by Application (2014-2019)
3 Global Prostate Cancer Diagnostics by Players
- 3.1 Global Prostate Cancer Diagnostics Sales Market Share by Players
- 3.1.1 Global Prostate Cancer Diagnostics Sales by Players (2017-2019)
- 3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Players (2017-2019)
- 3.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players
- 3.2.1 Global Prostate Cancer Diagnostics Revenue by Players (2017-2019)
- 3.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2017-2019)
- 3.3 Global Prostate Cancer Diagnostics Sale Price by Players
- 3.4 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Prostate Cancer Diagnostics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Prostate Cancer Diagnostics by Regions
- 4.1 Prostate Cancer Diagnostics by Regions
- 4.1.1 Global Prostate Cancer Diagnostics Consumption by Regions
- 4.1.2 Global Prostate Cancer Diagnostics Value by Regions
- 4.2 Americas Prostate Cancer Diagnostics Consumption Growth
- 4.3 APAC Prostate Cancer Diagnostics Consumption Growth
- 4.4 Europe Prostate Cancer Diagnostics Consumption Growth
- 4.5 Middle East & Africa Prostate Cancer Diagnostics Consumption Growth
5 Americas
- 5.1 Americas Prostate Cancer Diagnostics Consumption by Countries
- 5.1.1 Americas Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
- 5.1.2 Americas Prostate Cancer Diagnostics Value by Countries (2014-2019)
- 5.2 Americas Prostate Cancer Diagnostics Consumption by Type
- 5.3 Americas Prostate Cancer Diagnostics Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Prostate Cancer Diagnostics Consumption by Countries
- 6.1.1 APAC Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
- 6.1.2 APAC Prostate Cancer Diagnostics Value by Countries (2014-2019)
- 6.2 APAC Prostate Cancer Diagnostics Consumption by Type
- 6.3 APAC Prostate Cancer Diagnostics Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Prostate Cancer Diagnostics by Countries
- 7.1.1 Europe Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
- 7.1.2 Europe Prostate Cancer Diagnostics Value by Countries (2014-2019)
- 7.2 Europe Prostate Cancer Diagnostics Consumption by Type
- 7.3 Europe Prostate Cancer Diagnostics Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Prostate Cancer Diagnostics by Countries
- 8.1.1 Middle East & Africa Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Prostate Cancer Diagnostics Value by Countries (2014-2019)
- 8.2 Middle East & Africa Prostate Cancer Diagnostics Consumption by Type
- 8.3 Middle East & Africa Prostate Cancer Diagnostics Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Prostate Cancer Diagnostics Distributors
- 10.3 Prostate Cancer Diagnostics Customer
11 Global Prostate Cancer Diagnostics Market Forecast
- 11.1 Global Prostate Cancer Diagnostics Consumption Forecast (2019-2024)
- 11.2 Global Prostate Cancer Diagnostics Forecast by Regions
- 11.2.1 Global Prostate Cancer Diagnostics Forecast by Regions (2019-2024)
- 11.2.2 Global Prostate Cancer Diagnostics Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Prostate Cancer Diagnostics Forecast by Type
- 11.8 Global Prostate Cancer Diagnostics Forecast by Application
12 Key Players Analysis
- 12.1 Genomic Health
- 12.1.1 Company Details
- 12.1.2 Prostate Cancer Diagnostics Product Offered
- 12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Genomic Health News
- 12.2 Abbott
- 12.2.1 Company Details
- 12.2.2 Prostate Cancer Diagnostics Product Offered
- 12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Abbott News
- 12.3 OPKO
- 12.3.1 Company Details
- 12.3.2 Prostate Cancer Diagnostics Product Offered
- 12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 OPKO News
- 12.4 Siemens Healthcare
- 12.4.1 Company Details
- 12.4.2 Prostate Cancer Diagnostics Product Offered
- 12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Siemens Healthcare News
- 12.5 DiaSorin
- 12.5.1 Company Details
- 12.5.2 Prostate Cancer Diagnostics Product Offered
- 12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 DiaSorin News
- 12.6 BioMeriux
- 12.6.1 Company Details
- 12.6.2 Prostate Cancer Diagnostics Product Offered
- 12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 BioMeriux News
- 12.7 Roche
- 12.7.1 Company Details
- 12.7.2 Prostate Cancer Diagnostics Product Offered
- 12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Roche News
- 12.8 MDx Health
- 12.8.1 Company Details
- 12.8.2 Prostate Cancer Diagnostics Product Offered
- 12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 MDx Health News
- 12.9 Beckman Coulter
- 12.9.1 Company Details
- 12.9.2 Prostate Cancer Diagnostics Product Offered
- 12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Beckman Coulter News
- 12.10 Myriad Genetics
- 12.10.1 Company Details
- 12.10.2 Prostate Cancer Diagnostics Product Offered
- 12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Myriad Genetics News
- 12.11 Ambry Genetics
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Prostate Cancer Diagnostics . Industry analysis & Market Report on Prostate Cancer Diagnostics is a syndicated market report, published as Global Prostate Cancer Diagnostics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Prostate Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
